NCT01726621View on ClinicalTrials.gov

User Evaluation of the MiniMed 620G and 640G Insulin Pumps

NACompletedINTERVENTIONAL
Enrollment

55

Participants

Timeline

Start Date

March 31, 2013

Primary Completion Date

November 30, 2014

Study Completion Date

December 31, 2014

Conditions
Type 1 DiabetesType 2 Diabetes
Interventions
DEVICE

Medtronic MiniMed 620G or 640G Insulin Pump

Subjects to use the Medtronic MiniMed 620G or 640G Insulin Pump and Guardian Link transmitter to manage their diabetes for 4 - 6 weeks.

Trial Locations (6)

3050

The Royal Melbourne Hospital, Patkville

3065

St Vincent Hospital and The University of Melbourne, Fitzroy

Unknown

Herlev Hospital, Herlev

08036

Barcelona University Hospital, Barcelona

NW1 2PG

University College Hospital, London

SE5 9NU

King's College London, London

All Listed Sponsors
lead

Medtronic Diabetes

INDUSTRY

NCT01726621 - User Evaluation of the MiniMed 620G and 640G Insulin Pumps | Biotech Hunter | Biotech Hunter